- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.48 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.3: 6 residues within 4Å:- Chain A: G.125, Q.126, A.147, Y.148, S.150, N.151
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.151
NAG.4: 3 residues within 4Å:- Chain A: N.183, S.185, H.207
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.185
NAG.5: 5 residues within 4Å:- Chain A: D.527, S.529, N.551
- Ligands: NAG-NAG.1, NAG-NAG.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.527, A:N.551
- 2 x LP4: 2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-4-O-phosphono-beta-D-glucopyranose(Non-covalent)
LP4.6: 18 residues within 4Å:- Chain A: K.242
- Chain B: I.36, V.45, F.49, L.55, L.58, F.60, L.78, Y.86, F.88, I.101, P.102, F.103, S.104, F.105
- Ligands: LP5.7, DAO.8, MYR.9
15 PLIP interactions:14 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:I.36, B:V.45, B:F.49, B:L.55, B:L.58, B:F.60, B:L.78, B:F.88, B:I.101, B:F.103, B:F.105
- Hydrogen bonds: B:P.102, B:S.104, B:S.104
- Salt bridges: A:K.242
LP4.10: 19 residues within 4Å:- Chain C: K.242
- Chain D: I.36, V.45, V.47, F.49, L.55, L.58, F.60, L.78, Y.86, F.88, I.101, P.102, F.103, S.104, F.105
- Ligands: LP5.11, DAO.12, MYR.13
15 PLIP interactions:14 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:V.45, D:V.47, D:F.49, D:L.55, D:L.58, D:F.60, D:L.78, D:F.88, D:I.101, D:F.103, D:F.105
- Hydrogen bonds: D:P.102, D:S.104, D:S.104
- Salt bridges: C:K.242
- 2 x LP5: (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5-((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE(Non-covalent)
LP5.7: 17 residues within 4Å:- Chain A: K.339
- Chain B: L.38, V.66, L.71, R.74, F.105, E.106, G.107, I.108, F.110, F.135
- Chain C: S.392, R.413, F.417
- Ligands: LP4.6, DAO.8, MYR.9
21 PLIP interactions:15 interactions with chain B, 4 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: B:L.38, B:V.66, B:L.71, B:F.105, B:F.105, B:F.105, B:I.108, B:F.110, B:F.110, B:F.110, B:F.135, C:F.417
- Hydrogen bonds: B:R.74, B:E.106, B:G.107, B:I.108, C:S.392, C:S.392, C:R.413
- Salt bridges: A:K.339, A:K.339
LP5.11: 17 residues within 4Å:- Chain A: S.392, E.416, F.417
- Chain D: L.38, V.66, L.71, R.74, F.105, E.106, G.107, I.108, F.110, F.135, I.137
- Ligands: LP4.10, DAO.12, MYR.13
17 PLIP interactions:13 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:V.66, D:L.71, D:F.105, D:F.105, D:I.108, D:F.110, D:F.110, D:F.135, D:F.135, D:I.137, A:F.417, A:F.417
- Hydrogen bonds: D:E.106, D:G.107, D:I.108, A:S.392, A:S.392
- 2 x DAO: LAURIC ACID(Non-covalent)
DAO.8: 8 residues within 4Å:- Chain B: L.62, I.64, R.74, E.76, F.110, Y.115
- Ligands: LP4.6, LP5.7
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:L.62, B:I.64, B:F.110, B:Y.115
DAO.12: 6 residues within 4Å:- Chain D: L.38, R.74, F.110, Y.115
- Ligands: LP4.10, LP5.11
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.38, D:F.110, D:Y.115
- 2 x MYR: MYRISTIC ACID(Non-covalent)
MYR.9: 8 residues within 4Å:- Chain B: I.30, F.60, E.76, A.119, F.131, L.133
- Ligands: LP4.6, LP5.7
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:I.30, B:E.76, B:A.119, B:F.131, B:L.133
MYR.13: 10 residues within 4Å:- Chain D: I.30, F.60, L.62, E.76, V.77, A.119, F.131, L.133
- Ligands: LP4.10, LP5.11
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:I.30, D:F.60, D:F.60, D:L.62, D:E.76, D:A.119, D:F.131, D:L.133
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ohto, U. et al., Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-05-09
- Peptides
- Toll-like receptor 4: AC
Lymphocyte antigen 96: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.48 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 2 x LP4: 2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-4-O-phosphono-beta-D-glucopyranose(Non-covalent)
- 2 x LP5: (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5-((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE(Non-covalent)
- 2 x DAO: LAURIC ACID(Non-covalent)
- 2 x MYR: MYRISTIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ohto, U. et al., Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-05-09
- Peptides
- Toll-like receptor 4: AC
Lymphocyte antigen 96: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D